Stocks
IGC Pharma, Inc.IGC
AMEXHealthcareBiotechnology$0.25
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing IGC-AD1, a synthetic cannabinoid-based drug candidate for Alzheimer's disease agitation, alongside a line of hemp-derived CBD wellness products. Investors track it for its pipeline progress in neurodegenerative indications and its exposure to the cannabis-derived therapeutics market.
52W Range: $0.24-$0.45
Congressional Interest in IGC Pharma, Inc. (IGC)
No congressional trades have been disclosed for IGC Pharma, Inc. (IGC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IGC?
No congressional trades found for this stock.